OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-line PD-1 inhibitors combination therapy for patients with advanced cholangiocarcinoma: A retrospective real-world study
Ziqi Ye, Y. Zhang, Jie Chen, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110344-110344
Closed Access | Times Cited: 8
Ziqi Ye, Y. Zhang, Jie Chen, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110344-110344
Closed Access | Times Cited: 8
Showing 8 citing articles:
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 4
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 4
Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis
Mahyaar Omouri-Kharashtomi, Seyedeh Yasaman Alemohammad, Negin Moazed, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Mahyaar Omouri-Kharashtomi, Seyedeh Yasaman Alemohammad, Negin Moazed, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
Yichen Zheng, Jiamin Guo, Tianhui Ren, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yichen Zheng, Jiamin Guo, Tianhui Ren, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic marker
Patrick Sven Plum, Timo Hess, Denis Bertrand, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 1
Patrick Sven Plum, Timo Hess, Denis Bertrand, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 1
Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
Jia-yan Ni, Hongliang Sun, Ge-Fan Guo, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112872-112872
Closed Access | Times Cited: 1
Jia-yan Ni, Hongliang Sun, Ge-Fan Guo, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112872-112872
Closed Access | Times Cited: 1
Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
Yunyu Lian, Silüe Zeng, Sai Wen, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 4
Yunyu Lian, Silüe Zeng, Sai Wen, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 4
The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy
Zhiwei Zhang, Jingzhao Zhang, Ming Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Zhiwei Zhang, Jingzhao Zhang, Ming Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer
Wen‐Kuan Huang, Yan-Jei Tang, Chiao‐En Wu, et al.
The Oncologist (2024)
Open Access
Wen‐Kuan Huang, Yan-Jei Tang, Chiao‐En Wu, et al.
The Oncologist (2024)
Open Access
mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study
Zhipeng Sun, Hai Xu, Lei Yang, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 599-609
Open Access
Zhipeng Sun, Hai Xu, Lei Yang, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 599-609
Open Access
